![]()
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
New Zealand’s emissions trading scheme and
health: wasting our opportunities
Jamie Hosking, Jennie Connor, Scott Metcalfe, George Laking,
Andrea Forde, Rochelle Phipps; for OraTaiao: New Zealand Climate and
Health
The New Zealand Climate Change Response (Moderated Emissions
Trading) Amendment Bill will undergo its Second Reading in Parliament on 16
November 2009 and may be enacted as early as 17 November 2009 under
urgency.
New Zealand’s emissions trading scheme (ETS) is thus
not quite yet finalised. Important decisions regarding the scheme are still
being made, and have the potential to drastically alter the effect of the
scheme, including its health implications.
The health consequences of runaway climate change have now
been extensively described.1,2 Climate change
has been characterised by our Prime Minister’s Chief Science Advisor as
‘a tragedy of the commons’3—a
situation where common goods are destroyed because no-one individually bears the
cost of their destruction. To play our part in keeping the planet habitable, we
need to halve our current emission levels—i.e. reduce New Zealand’s
greenhouse gas emissions by at least 40% by
2020,1 and 80-90% by 2050 below 1990
levels.
Several mechanisms are relevant to this, including fuel
economy, insulation, and renewable generation.4
The mechanism that has taken centre stage politically and governmentally is that
of ETSs, which work by attaching a price to greenhouse gases. This creates a
market in which the right to pollute must be purchased and can be traded,
allowing emission cuts to occur where it is least costly to do so. The
Government’s role is to set the limit on total emissions available to be
traded in the market.4
ETSs have not previously been routine health business.
However, they have major implications for health for two reasons. First, they
are a key mechanism for lowering greenhouse gas emissions. Second, they may
involve transfers of large amounts of money. Unfortunately, public health has
not been an important consideration in the design of New Zealand’s current
scheme.
Earlier this year, Dhar et
al5 discussed the public health implications of
emissions pricing, noting that there was the potential for a ‘triple
dividend’ for health if the policies are right.
They identified potential public health gains through:
However, how much each of these health gains will
occur in response to an ETS will depend on how much emitters bear the costs of
emissions.
Current proposed amendments to ETS legislation provide for
free, intensity-based allocation of emission units to polluters; a further 2
years’ delay for the entry of the agriculture sector into the ETS (2015);
a cap on the price of emission units; and a ‘2 for 1 deal’ whereby
emitters need only surrender one tonne of units for every 2 tonnes of emissions,
in effect halving the emissions price to just $12.50 per tonne. All of these
provisions reduce the cost of greenhouse gas emissions to emitters, and thereby
reduce all of the potential benefits to health.
An ETS can provide a financial incentive to reduce
emissions, since under an ETS lower emissions mean lower costs for businesses.
This lessens the probability and scale of runaway climate change and the threat
to basic human needs: adequate and safe water and food, shelter, political
security, and human settlements.2,5, 6
The currently proposed amendments to New Zealand’s
emissions trading scheme include the setting of an emissions reduction target of
50% by 2050. While the inclusion in legislation of a target is a positive step,
the level is weak; we need to at least halve our emissions over this
decade—not 40 years hence—and prepare for virtually no net emissions
from 2050.1
Emissions reductions are needed rapidly. It may be
reasonable for emitters to ask that the Government find some way to initially
cushion the blow, but there is no room to delay the cuts themselves.
New Zealand has an international role. While we are
responsible for only a small proportion of global greenhouse emissions, in
per-capita terms we rank much higher.7 If New
Zealand sets targets that are not commensurate with its status and
responsibilities as a developed nation,1 then
we sabotage global co-operative action on climate change, reducing the extent to
which other countries are prepared to cut emissions.
More certainly, this ETS and our low target will sabotage
our own economy, both directly and indirectly. Directly, for example, because we
(like Australia) are a coastal society; just 3 days ago an Australian Government
report said that AUS$150 billion worth of property is at risk there from rising
sea levels and more frequent storms.8 And
indirectly because in the global transition to low-emission economic
development, ‘latecomers will be
losers’.9
China, which is now positioning itself to be the global
energy efficiency leader, points out that it will be very hard for countries
that have weak emissions reduction targets to develop new technology of their
own.9 While harmonisation with Australia (whose
scheme is not yet finalised) has been part of the rationale for amending and
weakening New Zealand’s ETS, this will put us further out of step with
more relevant global actors such as China.
Attaching a price to greenhouse gas emissions makes
low-emission strategies more financially attractive. For example, walking and
cycling become more attractive options compared with private car use. A shift
from car use to more active and public transport benefits health through the
promotion of physical activity, safer roads, and reduced air
pollution.10,11
The price signal of an ETS will also help other shifts
relevant to health: more energy-efficient housing improves health by reducing
the vulnerability of occupants to extremes of heat and cold and associated
health effects,12–14 while reducing
population intake of animal products could reduce the emissions footprint of the
New Zealand diet,15 as well as reducing the
prevalence of heart disease and bowel
cancer.16
Appropriate emissions pricing can produce a revenue stream
for governments, through the domestic sale of emission permits to large
emitters, which could be “recycled” for health improvement. However,
the net impact of the proposed ETS on large industries, taking account of both
direct and “indirect” (via electricity use) emissions, is more than
a $754 million emission subsidy.17
As well as this, by setting different proportions each
sector will be liable for over different time periods (e.g. agriculture), the
scheme produces wide disparities—particularly affecting households, road
users, and small and medium enterprises. This has been described as
‘corporate welfare’ for big
polluters.18
This is not the best use of more than $754 million dollars
of taxpayer resources. It would be more than the annual budget of most of the
District Health Boards (DHBs) in New Zealand, and would pay for the combined DHB
deficit (at $150 million at the end of 200819)
five times over.
Such subsidies for big polluters will siphon public funds
away from other public services. Māori, Pacifica, refugee, and low-income
New Zealanders are likely to disproportionately suffer the consequences, with
adverse effects on health, social, and equity outcomes.
If New Zealand’s ETS increases health inequality, it
is likely to do so in both socio-economic and ethnic dimensions. Given the
higher proportion of Māori, Pacifica, and refugee families on low incomes,
these groups are at particular risk from the price effects of an ETS. Although
the most recent amendments to the New Zealand ETS notionally provide for a
Treaty of Waitangi clause, it is difficult to see how Treaty principles can be
upheld in the ETS unless accompanied by action to reduce fuel poverty and food
insecurity—burdens that fall disproportionately on Māori
families.
Economic instruments are essential to address climate
change,6,20,21 though insufficient by
themselves.4 New Zealand needs an effective
all-sectors all-gases cross-party emissions trading scheme with an uncapped
market price on greenhouse gas emissions. But the proposed amended scheme, now
at Select Committee stage, places considerable costs on taxpayers, affecting
those least able to afford it, whilst creating large subsidies for big
polluters. If the Bill is allowed to be passed in its current form, we risk
increasing emissions and eventually driving the New Zealand economy into the
ground.
Emissions trading schemes in themselves are intrinsically
neither beneficial nor harmful to health. However, depending on how they are
designed, the potential health effects are great. The right ETS could have a
fourfold dividend for health: avoiding effects of climate change; providing
additional revenue for health and social spending or further emissions
reduction; incentivising healthy transport, healthy housing, healthy nutrition
and other emissions reduction co-benefits; and improving health equity. We are
currently at risk of squandering the opportunity for spending on health and
other public services; and increasing health and social inequality.
New Zealand has a duty to reduce emissions to an extent that
is fair on a global scale1 and to influence
larger nations. Reductions must also be equitable on a local scale.
New Zealand’s emissions trading scheme must therefore
be better designed, to lead to both emissions reduction and health improvement.
This should include:
These measures will help ensure an
emissions trading scheme that benefits the economy, health, and well-being as
well as the climate.
For more detail and explanation of issues raised in this
article please see http://www.nzma.org.nz/journal/122-1305/3859/OraTaiao.pdf
or the OraTaiao: New Zealand Climate and Health website
www.nzchg.webs.com
Competing interests: This paper is
authored by individual health professionals belonging to, and on behalf of,
OraTaiao: New Zealand Climate and Health1 (www.nzchg.webs.com). OraTaiao submitted in
writing and orally to the Finance and Expenditure Select Committee on the
Climate Change Response (Moderated Emissions Trading) Amendment Bill. Members of
OraTaiao submitted a further six written submissions to the Select Committee as
individuals, four presented orally.
Author information: Jamie Hosking, Public
Health Physician, Auckland; Jennie Connor, Public Health Physician, Auckland,
Scott Metcalfe, Public Health Physician, Wellington; George Laking, Medical
Oncologist/Health Economist, Auckland; Andrea Forde, Public Health Medicine,
Canberra, Australia (ex Wellington); Rochelle Phipps, General Practitioner,
Christchurch
Acknowledgements: We thank John McCall,
Alex Macmillan, Rhys Jones, Osman Mansoor, Richard Jaine, Graeme Lindsay, David
Sinclair, Divya Dhar, Ed Kiddle, Andrew Holmes, Philippa Howden-Chapman, Stephen
Palmer, Susan Wells, Anne MacLennan, Joanna Santa Barbara, Rachel Highton, Moana
Tane, Marama Parore, and Liz Springford.
Correspondence: Jamie Hosking, Public
Health Physician, Section of Epidemiology and Biostatistics, School of
Population Health, University of Auckland, Private Bag 92019, Auckland, New
Zealand. Email: jamie.hosking@auckland.ac.nz;
OraTaiao: New Zealand Climate and Health website (interim): www.nzchg.webs.com
References:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Current
issue | Search journal |
Archived issues | Classifieds
| Hotline (free ads) Subscribe | Contribute | Advertise | Contact Us | Copyright | Other Journals |